Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women

Completed · Phase 3

Conditions studied: Nausea and Vomiting, Postoperative, Postoperative Nausea and Vomiting

In brief

This study is being conducted to see if adding GW679769 (casopitant) to ZOFRAN will significantly decrease the number of patients who experience nausea and vomiting after surgery.

Key facts

Study ID

NCT00334152

Run by

GlaxoSmithKline

People needed

515

Starts

2006-03-01

Expected to finish

2006-07-01

Last updated by the study team

2017-03-23

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• History of PONV (postoperative nausea and vomiting) and/or motion sickness.
• Have not smoked for the last 6 months.
• Having certain abdominal, breast, thyroid or shoulder surgery.

You may not qualify if…

• Pregnant or breastfeeding.
• Have certain pre-existing medical conditions or take certain medications.

Where it is running

• GSK Investigational Site — Mobile, Alabama, United States
• GSK Investigational Site — Montgomery, Alabama, United States
• GSK Investigational Site — Little Rock, Arkansas, United States
• GSK Investigational Site — Arcadia, California, United States
• GSK Investigational Site — Glendale, California, United States
• GSK Investigational Site — Laguna Hills, California, United States
• GSK Investigational Site — Pasadena, California, United States
• GSK Investigational Site — Boca Raton, Florida, United States
• GSK Investigational Site — Melbourne, Florida, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — West Palm Beach, Florida, United States
• GSK Investigational Site — Chicago, Illinois, United States
• GSK Investigational Site — Kansas City, Kansas, United States
• GSK Investigational Site — Baltimore, Maryland, United States
• GSK Investigational Site — Royal Oak, Michigan, United States
• GSK Investigational Site — Mineola, New York, United States
• GSK Investigational Site — New Hyde Park, New York, United States
• GSK Investigational Site — New York, New York, United States
• GSK Investigational Site — Winston-Salem, North Carolina, United States
• GSK Investigational Site — Cincinnati, Ohio, United States
• GSK Investigational Site — Oklahoma City, Oklahoma, United States
• GSK Investigational Site — Charlottesville, Virginia, United States
• GSK Investigational Site — Winchester, Virginia, United States
• GSK Investigational Site — Seattle, Washington, United States
• GSK Investigational Site — Fairhope, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.